AmeriCann Added to LD Micro Index and Proposed Cannabis ETF
Emerging AgroSphere
DENVER, CO -- February 21, 2017 -- InvestorsHub NewsWire --
AmeriCann, Inc. (OTCQX: ACAN), an Ag-Tech company that is
developing sustainable, state-of-the-art medical cannabis
cultivation properties, is pleased to announce it has been added to
the LD Micro Index as of February 1st, 2017. In addition, AmeriCann
is included in the proposed first cannabis exchange-traded fund
(ETF), the Emerging AgroSphere ETF.
The LD Micro Index is designed to give the most accurate
representation of the intraday activity of microcap stocks in North
America. Criteria for inclusion can be found at the following link:
http://www.ldmicro.com/the-index
The index is market cap weighted and is comprised of
approximately 1,000 stocks in the U.S. and Canada. Included stocks
have a market capitalization between $50 million and $300 million
and an average daily traded value of $50,000 over the preceding 3
months.
LD Micros David Scher stated, "We have been monitoring AmeriCann
for some time now and are truly pleased to see them included in the
index. This is a company that has performed incredibly well from a
business perspective, as well as an investment perspective."
ETF Managers Group, based in Summit, New Jersey, has filed an
initial registration statement
for what could be the first cannabis exchange-traded fund (ETF),
the Emerging AgroSphere ETF. The proposed fund will be focused on
medical cannabis and will not invest in any companies that are
focused on serving the non-medical marijuana market in the United
States, Canada or any other country unless and until such time as
the production and sale of non-medical marijuana becomes legal in
the United States, Canada or such other country, respectively.
AmeriCann is developing a 53-acre property in Massachusetts
(acquired from Boston Beer Company (SAM-NYSE) for $4,475,000 in
cash), as the Massachusetts Medical Cannabis Center (the MMCC). The
MMCC is approved for 1 million square feet and is expected to be
one of the largest and most technologically advanced cannabis
cultivation facilities in the nation.
The regulated cannabis industry is one of the fastest growing
industries in the country. The respected Wall Street firm of Cowen
& Co recently released a research report projecting dramatic
growth for the industry from the current $7 billion nationally to
over $50 billion in ten years.
Massachusetts, California, Maine, and Nevada voted to legalize
recreational marijuana while Arkansas and North Dakota approved
medical cannabis initiatives. Florida voters approved medical
marijuana in a landslide with over 71% of the vote. With
these election results, over 60% of the US Population now live in
states where medical cannabis is now legal.
About AmeriCann
AmeriCann is a publicly traded Ag-Tech company that is
developing and sustainable, state-of-the-art medical cannabis
cultivation properties. The Company has over 1,000,000 square feet
of facilities in the planning and design stages of development. The
Company has designed a proprietary line of cannabis infused
products which will be branded and licensed to companies in
regulated markets.
AmeriCann, Inc. is a Certified B
Corp, an acknowledgment of the companys commitment to social
and environmental ethics, transparency and accountability. AmeriCann became the first public
cannabis company to earn this respected accreditation. More
information about the Company is available at: www.americann.co or follow AmeriCann on Twitter @ACANinfo
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an
independent resource in the microcap space. What started out as a
newsletter highlighting unique companies has transformed into an
event platform hosting several influential conferences annually
(Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi)
to exclusively provide intraday information on the entire sector.
LD will continue to provide valuable tools for the benefit of
everyone in the small and microcap universe.
About Massachusetts Medical Cannabis Center
The Massachusetts Medical Cannabis Center is approved for
nearly 1,000,000 square feet of medical cannabis
cultivation and processing in Freetown, Massachusetts. The
state-of-the-art, sustainable, greenhouse project will consist of
multiple planned phases for tenants in the Massachusetts medical
marijuana market. AmeriCanns Cannopy System uniquely combines
expertise from traditional horticulture, lean manufacturing,
regulatory compliance and cannabis cultivation to create superior
facilities and procedures.
The first phase of the project consists of 130,000 sq. ft. of
cultivation and processing infrastructure. AmeriCann can expand the
first phase to approximately 600,000 sq. ft., based on patient
demand.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended (the Exchange Act) (which Sections were adopted as part of
the Private Securities Litigation Reform Act of 1995). Statements
preceded by, followed by or that otherwise include the words
believe, anticipate, estimate, expect, intend, plan, project,
prospects, outlook, and similar words or expressions, or future or
conditional verbs such as will, should, would, may, and could are
generally forward-looking in nature and not historical facts. These
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the Company's
actual results, performance or achievements to be materially
different from any anticipated results, performance or
achievements. The Company disclaims any intention to, and
undertakes no obligation to, revise any forward-looking statements,
whether as a result of new information, a future event, or
otherwise. For additional uncertainties that could impact the
Company's forward-looking statements, please see the Companys
Annual Report on Form 10-K for the year ended September 30, 2016,
which the Company has filed with the SEC and which may be viewed at
http://www.sec.gov.
Contact Information:
Corporate:
AmeriCann, Inc.
3200 Brighton Blvd. Unit 114
Denver, CO 80216
(303) 862-9000
info@americann.co
www.americann.co
@ACANinfo on Twitter
Investors:
Hayden IR
hart@haydenir.com
(917) 658-7878